[DOI] [PubMed] [Google Scholar] 56.Vukojevic J., Siroglavic M., Kasnik K., Kralj T., Stancic D., Kokot A., Kolaric D., Drmic D., Sever A.Z., Barisic I., et al
Among 173 RA patients with overweight or obesity who were prescribed GLP-1 agonists and actually took them, 32% showed improvement in RA disease activity after 1 year, compared with 17% of 42 patients who were also prescribed the drugs but never started them, according to Veena Ranganath, MD, MS, of the University of California Los Angeles (UCLA), and colleagues
It protects cells from damage and helps regulate melanin formation
However, Dr
Kisspeptin A peptide involved in reproductive hormone signaling and hormonal regulation
Adems, se estn evaluando nuevas indicaciones para los medicamentos GLP-1, como la enfermedad heptica metablica, la enfermedad arterial perifrica y los trastornos neurodegenerativos